The trademark application Lollifen was filed by G.L. Pharma GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on January 31, 2022, and it was registered by office on May 10, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).